AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 74 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $13 | +225.0% | 800 | -81.4% | 0.00% | – |
| Q1 2023 | $4 | +33.3% | 4,300 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -99.7% | 4,300 | +168.8% | 0.00% | – |
| Q3 2022 | $1,000 | -95.8% | 1,600 | -95.9% | 0.00% | -100.0% |
| Q2 2022 | $24,000 | -81.5% | 39,498 | -37.5% | 0.00% | -85.7% |
| Q1 2022 | $130,000 | +364.3% | 63,201 | +1014.9% | 0.01% | +600.0% |
| Q4 2021 | $28,000 | – | 5,669 | +5569.0% | 0.00% | – |
| Q4 2020 | $0 | – | 100 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 100 | -98.6% | 0.00% | -100.0% |
| Q2 2020 | $15,000 | -44.4% | 7,300 | -20.7% | 0.00% | -50.0% |
| Q1 2020 | $27,000 | -86.7% | 9,200 | -56.3% | 0.00% | -75.0% |
| Q1 2017 | $203,000 | – | 21,065 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,305,017 | $18,625,000 | 7.73% |
| COWEN AND COMPANY, LLC | 3,732,778 | $30,161,000 | 2.74% |
| GENDELL JEFFREY L | 2,446,299 | $19,766,000 | 1.60% |
| Asymmetry Capital Management, L.P. | 369,134 | $2,983,000 | 1.58% |
| Vivo Capital, LLC | 2,937,093 | $23,732,000 | 1.43% |
| Samsara BioCapital, LLC | 659,409 | $5,328,000 | 1.03% |
| Altium Capital Management LP | 440,589 | $3,560,000 | 0.98% |
| Knott David M Jr | 258,198 | $2,086,000 | 0.71% |
| RTW INVESTMENTS, LP | 5,741,939 | $46,395,000 | 0.68% |
| FRAZIER MANAGEMENT LLC | 951,814 | $7,691,000 | 0.59% |